Smith & Nephew plc ADR Stock
Smith & Nephew plc ADR Stock
The Smith & Nephew plc ADR price is unchanged compared to yesterday.
Pros and Cons of Smith & Nephew plc ADR in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Smith & Nephew plc ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Smith & Nephew plc ADR | 0.000% | -2.941% | -0.752% | -14.286% | -5.714% | 2.326% | -19.512% |
| Smith & Nephew plc | -0.770% | -5.797% | -1.515% | -17.224% | -8.547% | -0.383% | -21.260% |
| Steris Corp. | -2.140% | 0.097% | 12.057% | -2.190% | -5.780% | -0.097% | 11.268% |
| Humana Inc. | -1.200% | 5.696% | -4.023% | 45.788% | 52.095% | -25.827% | -6.338% |
Comments
Smith & Nephew SNATS (SNN) had its "overweight" rating reaffirmed by Morgan Stanley.
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) had its "buy" rating reaffirmed by The Goldman Sachs Group, Inc..
Show more
Ratings data for SNN provided by MarketBeat
Smith & Nephew SNATS (SNN) was upgraded by Wall Street Zen from "buy" to "strong-buy".
Show more
Ratings data for SNN provided by MarketBeat